The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of mutant KRAS as a biomarker in FL118-induced apoptosis, reactive oxygen species (ROS) production and inhibition of survivin, Mcl-1 and XIAP in human bladder cancer.
 
Sreevidya Santha
No Relationships to Disclose
 
Ieman Aljahdali
No Relationships to Disclose
 
Sailee Suryakant Rasam
No Relationships to Disclose
 
Xue Wang
No Relationships to Disclose
 
Xiang Ling
Employment - Canget BioTekpharma
Stock and Other Ownership Interests - Canget BioTekpharma
Patents, Royalties, Other Intellectual Property - Canget BioTekpharma
 
Jianqun Liao
No Relationships to Disclose
 
Jue Wang
No Relationships to Disclose
 
Christos Fountzilas
Research Funding - Astellas Pharma (Inst); Incyte (Inst); Kinex (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst)
 
Qingyong Li
No Relationships to Disclose
 
Jun Qu
No Relationships to Disclose
 
Fengzhi Li
Employment - Canget BioTekpharma (I)
Leadership - Canget BioTekpharma (I)
Stock and Other Ownership Interests - Canget BioTekpharma
Patents, Royalties, Other Intellectual Property - Canget BioTekpharma
Travel, Accommodations, Expenses - Canget BioTekpharma
(OPTIONAL) Uncompensated Relationships - Canget BioTekpharma